The BioFire® Respiratory 2.1 plus (RP2.1plus) Panel identifies the most common viral and bacterial pathogens—including SARS-CoV-2—that cause respiratory tract infections, which can present with nearly indistinguishable symptoms. An unprecedented run time of about 45 minutes enables higher efficiency and throughput on the BioFire® 2.0 and the BioFire® Torch Systems, and offers faster results to clinicians, potentially enabling better-informed diagnosis and treatment of patients. Higher overall sensitivity across a broader spectrum of pathogens means the BioFire RP2.1plus Panel offers the world the fastest way to better results in the detection of respiratory pathogens.